Evidence map›Paper›PMID 29233972›Full record

ArticleNature communications2017

IRF8-dependent molecular complexes control the Th9 transcriptional program.

Etienne Humblin, Marion Thibaudin, Fanny Chalmin, Valentin Derangère, Emeric Limagne, Corentin Richard, Richard A Flavell, Sandy Chevrier, Sylvain Ladoire, Hélène Berger and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 62 citations in OpenAlex.

  1. Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  19. Article
  20. The Dichotomy of Interleukin-9 Function in the Tumor Microenvironment.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Etienne HumblinUniv. Bourgogne Franche-Comté, F-21000, Dijon, France.
Marion ThibaudinUniv. Bourgogne Franche-Comté, F-21000, Dijon, France.
Fanny ChalminCentre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France.
Valentin DerangèreUniv. Bourgogne Franche-Comté, F-21000, Dijon, France.
Emeric LimagneCentre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France.
Corentin RichardUniv. Bourgogne Franche-Comté, F-21000, Dijon, France.
Richard A FlavellDepartment of Immunobiology, Yale University, School of Medicine, New Haven, CT, 06510, USA.
Sandy ChevrierPlatform of Transfer in Cancer Biology, Centre Georges-François Leclerc, F-21000, Dijon, France.
Sylvain LadoireUniv. Bourgogne Franche-Comté, F-21000, Dijon, France.
Hélène BergerUniv. Bourgogne Franche-Comté, F-21000, Dijon, France.
Romain BoidotCentre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France.ORCID http://orcid.org/0000-0001-9956-1737
Lionel ApetohCentre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France.ORCID http://orcid.org/0000-0002-2774-438X
Frédérique VégranCentre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France. frederique.vegran@inserm.fr.
François GhiringhelliUniv. Bourgogne Franche-Comté, F-21000, Dijon, France. fghiringhelli@cgfl.fr.
Inserm · FRCentre Georges François Leclerc · FRHoward Hughes Medical Institute · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Interferon regulatory factors (IRF) have critical functions in lymphoid development and in immune response regulation. Although many studies have described the function of IRF4 in CD4

Indexed as

AnimalsBasic-Leucine Zipper Transcription FactorsCell DifferentiationFemaleGene Knockdown TechniquesHumansInterferon Regulatory Factor-4Interferon Regulatory Factor-8Interferon Regulatory FactorsInterleukin-9MelanomaMiceMice, Inbred C57BLProto-Oncogene ProteinsProto-Oncogene Protein Spi-1RNA, Small InterferingBasic-Leucine Zipper Transcription FactorsBatf protein, mouseInterferon Regulatory Factor-4Interferon Regulatory Factor-8Interferon Regulatory FactorsInterleukin-9Proto-Oncogene ProteinsProto-Oncogene Protein Spi-1RNA, Small InterferingTrans-Activators

Identifiers

PMID29233972
PMCPMC5727025
OpenAlexW2774476207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.